Kynam Capital Management, LP Cogent Biosciences, Inc. Put Options Transaction History
Kynam Capital Management, LP
- $953 Million
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding COGT
# of Institutions
159Shares Held
102MCall Options Held
197KPut Options Held
102K-
State Street Corp Boston, MA7.63MShares$64.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.69MShares$56.4 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct6.68MShares$56.3 Million0.11% of portfolio
-
Commodore Capital LP New York, NY6.43MShares$54.2 Million3.73% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.21MShares$52.4 Million4.4% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $554M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...